SELECTIVE INVIVO INHIBITION BY QUINIDINE OF METHOXYPHENAMINE OXIDATION IN RAT MODELS OF HUMAN DEBRISOQUINE POLYMORPHISM

被引：14

作者：

MURALIDHARAN, G ^{[1
]}

MIDHA, KK ^{[1
]}

MCKAY, G ^{[1
]}

HAWES, EM ^{[1
]}

INABA, T ^{[1
]}

机构：

[1] UNIV TORONTO,FAC MED,DEPT PHARMACOL,TORONTO M5S 1A8,ONTARIO,CANADA

来源：

XENOBIOTICA | 1989年 / 19卷 / 02期

关键词：

D O I：

10.3109/00498258909034691

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：189 / 197

页数：9

共 22 条

[1] ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS [J].

ALDABBAGH, SG ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) :161-164

[2] BUFURALOL 1'-HYDROXYLASE ACTIVITY OF THE RAT - STRAIN DIFFERENCES AND THE EFFECTS OF INHIBITORS [J].

BOOBIS, AR ;

SEDDON, CE ;

DAVIES, DS .

BIOCHEMICAL PHARMACOLOGY, 1986, 35 (17) :2961-2965

[3] SPARTEINE OXIDATION IS PRACTICALLY ABOLISHED IN QUINIDINE-TREATED PATIENTS [J].

BRINN, R ;

BROSEN, K ;

GRAM, LF ;

HAGHFELT, T ;

OTTON, SV .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) :194-197

[4]

GUENGERICH FP, 1986, MOL PHARMACOL, V30, P287

[5] METHOXYPHENAMINE O-DEMETHYLASE AND 5-HYDROXYLASE - A GLC-ECD ASSAY TO STUDY THEIR ACTIVITIES AND THEIR INHIBITION BY DEBRISOQUINE AND SPARTEINE [J].

HAWES, EM ;

ROY, SD ;

MCKAY, G ;

MIDHA, KK .

PHARMACOLOGY & THERAPEUTICS, 1987, 33 (01) :73-77

[6] QUINIDINE - POTENT INHIBITION OF SPARTEINE AND DEBRISOQUINE OXIDATION INVIVO [J].

INABA, T ;

TYNDALE, RE ;

MAHON, WA .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) :199-200

[7]

INABA T, 1985, DRUG METAB DISPOS, V13, P443

[8]

INOUE T, 1980, HOKAGAKU HEN, V33, P33

[9] GENETICALLY-DETERMINED POLYMORPHISMS IN DRUG OXIDATION [J].

JACQZ, E ;

HALL, SD ;

BRANCH, RA .

HEPATOLOGY, 1986, 6 (05) :1020-1032

[10] GENETIC-VARIATION IN THE HUMAN HEPATIC CYTOCHROME-P-450 SYSTEM [J].

KALOW, W .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 31 (06) :633-641

← 1 2 3 →